Invention Grant
US08222284B2 Stable formulations of thiadiazole derivative 失效
稳定的噻二唑衍生物制剂

Stable formulations of thiadiazole derivative
Abstract:
The present invention provides formulation parameters and manufacturing conditions for stable pharmaceutical compositions comprising N-{4-(2,2-dimethyl-propionyl)-(5R)-5-[(2-ethylamino-ethanesulfonylamino)-methyl]-5-phenyl-4,5-dihydro-[1,3,4]thiadiazol-2-yl}-2,2-dimethyl-propionamide that minimize undesirable chiral conversion to the less active S enantiomeric form.
Public/Granted literature
Information query
Patent Agency Ranking
0/0